- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
Exhibit 15.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form F-3, as currently amended (No. 333-104121) and in the Registration Statements on Form S-8 (Nos. 333-13022, 333-88966 and 333-100388) of GlaxoSmithKline plc of our report dated 1 March 2006, relating to the financial statements of GlaxoSmithKline plc, which appears in GlaxoSmithKline plc’s Annual Report on Form 20-F for the year ended 31 December 2005, and of our report dated 2 March 2005, except for the Cidra, Puerto Rico manufacturing site matter discussed in Note 30, for which the date is 8 March 2005, relating to the financial statements of GlaxoSmithKline plc, which appears in GlaxoSmithKline plc’s Annual Report on Form 20-F for the year ended 31 December 2004. We also consent to the reference to us under the heading Experts in the Registration Statement on Form F-3.
/s/ PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP
London, England
3 March 2006